Sanofi and GSK target Q4 2021 for COVID-19 vaccine rollout

Sanofi and GSK target Q4 2021 for COVID-19 vaccine rollout

Source: 
Biopharma Reporter
snippet: 

Sanofi and GSK have initiated a new Phase 2 study for their COVID-19 vaccine candidate; with a Phase 3 study set to follow in Q2 and potential rollout of the vaccine in Q4.